Trial of Semaglutide for Diabetic Kidney Disease in Type 1 Diabetes
Conditions
Diabetic Kidney Disease · Type 1 Diabetes
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of Colorado Anschutz Medical Campus, Aurora, Colorado, United States
Contact: Study coordinator (Madeline Harbour, BA) · madeline.harbour@childrenscolorado.org · 720-689-4751Contact: Study coordinator (Carissa Birznieks, BS) · carissa.birznieks@cuanschutz.edu · 720-689-4751Contact: Principal Investigator (Jessica Kendrick, MD)University of Washington, Seattle, Washington, United States
Contact: Principal Investigator (Irl Hirsch, MD)Providence Sacred Heart Medical Center, Spokane, Washington, United States
Contact: Principal Investigator (Katherine Tuttle, MD)Toronto General Hospital, University Health Network, Toronto, Ontario, Canada
Contact: Principal Investigator (David Cherney, MD CM PhD)
Study leads
Ian de Boer, MD, MS
Principal Investigator
University of Washington
Jessica Kendrick, MD
Principal Investigator
University of Colorado Anschutz Medical Campus and Children's Hospital Colorado
David Cherney, PhD, MD
Principal Investigator
University of Toronto
Irl Hirsch, MD
Principal Investigator
University of Washington
Katherine Tuttle, MD
Principal Investigator
Providence Healthcare